Latest Breaking News On - Robert sergott - Page 2 : comparemela.com
For some Alzheimer s patients, vision problems may be early warning
calgarysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calgarysun.com Daily Mail and Mail on Sunday newspapers.
GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
16 Dec 2020
BACE inhibitors succeeded in stemming the tide of Aβ production in the brain, but the drugs also slightly dulled cognition and shrank the brain, bringing the trials to a screeching halt. Rather than washing their hands of a failure and moving on, researchers continue to dig through the trial data to find out exactly what happened, and perhaps even to chart a way forward for the drugs. Three recent studies all led by Michael Egan at Merck add new insight.
Verubecestat triggered a rapid atrophy that did not get worse.
This happened in amyloid-rich regions, and did not track with neurodegeneration.